Section Arrow
Quote
TRIB.NASDAQ
- Trinity Biotech plc
Quotes are at least 15-min delayed:2025/02/01 11:52 EST
Last
 0.9
-0.025 (-2.70%)
Day High 
1.01 
Prev. Close
0.925 
1-M High
1.48 
Volume 
441.82K 
Bid
0.88
Ask
0.95
Day Low
0.8631 
Open
1.01 
1-M Low
0.74 
Market Cap 
25.46M 
Currency USD 
P/E 0.55 
%Yield 24.44 
10-SMA 0.91 
20-SMA 0.9 
50-SMA 0.96 
52-W High 3.55 
52-W Low 0.74 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.33/-0.49
Enterprise Value
90.98M
Balance Sheet
Book Value Per Share
-0.96
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
56.83M
Operating Revenue Per Share
2.63
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SENSSenseonics Holdings0.9608-0.1292-11.85%-- 
QSIQuantum-Si1.98+0.02+1.02%-- 
PACBPacific Biosciences of California1.54-0.06-3.75%-- 
MDTMedtronic plc90.82-1.17-1.27%28.13PE
ABTAbbott Laboratories127.93-0.88-0.68%39.2PE
Quotes are at least 15-min delayed：2025/02/01 11:52 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.